市場調査レポート
商品コード
1521183
ライフサイエンスBPO市場レポート:サービスタイプ、用途、地域別、2024年~2032年Life Sciences BPO Market Report by Service Type (Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales and Marketing Outsourcing), Application (Clinical Trials, Patient-Centric, R&D Activities, Digital Era), and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ライフサイエンスBPO市場レポート:サービスタイプ、用途、地域別、2024年~2032年 |
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2~3営業日
|
世界のライフサイエンスBPOの市場規模は、2023年に4,130億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけての成長率(CAGR)は7.46%を示し、2032年には8,042億米ドルに達すると予測しています。効率的かつ効果的な問題解決と管理に対するニーズの高まり、研究開発(R&D)活動への注力強化、急速な技術進歩、ヘルスケア産業の著しい成長が、市場を牽引する主な要因のひとつです。
ライフサイエンスビジネスプロセスアウトソーシング(BPO)は、ライフサイエンス業界のさまざまなビジネスプロセスや機能を第三者プロバイダーにアウトソーシングするものです。組織の運営と成長をサポートする専門的なサービスを提供します。臨床試験、ファーマコビジランス、メディカルライティング、データ管理などで広く利用されています。ライフサイエンスBPOは、専門知識の活用、コスト削減、業務効率化、拡張性、法規制コンプライアンスの向上など、さまざまなメリットを提供します。ライフサイエンスBPOは、医薬品、バイオテクノロジー、医療機器、臨床研究、ヘルスケアなどのライフサイエンス分野の企業の業務、研究開発、製造、法規制遵守をサポートする幅広い活動やサービスを包含しています。
慢性疾患の世界の蔓延は、市場成長を促進する重要な要因のひとつです。ライフサイエンスBPOプロバイダーは、複雑なヘルスケアデータの収集、分析、整理、報告を支援します。これに伴い、BPOサービスは疾病パターン、治療結果、患者集団に関するより良い洞察を可能にし、個別化医療とエビデンスに基づくヘルスケアソリューションの市場開拓に貢献します。これとは別に、クラウドコンピューティング、ビッグデータ分析、人工知能(AI)、ロボットによるプロセス自動化(RPA)などの急速な技術進歩により、BPOプロバイダーは高度なデータ管理、分析、自動化ソリューションを提供できるようになり、市場成長に弾みをつけています。さらに、ライフサイエンスBPOは、インフラ構築、人材派遣、トレーニング、メンテナンスに関連する運用コストを削減することで、企業にコスト削減の機会を提供しており、これが市場成長にプラスの影響を与えています。その他の要因としては、効率的かつ効果的な問題解決と管理に対するニーズの高まり、研究開発(R&D)活動への注力の強化、情報技術(IT)環境の複雑化、ファーマコビジランス分野の著しい成長などが挙げられ、市場成長の原動力になると予想されます。
The global life sciences BPO market size reached US$ 413.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 804.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.46% during 2024-2032. The growing need for efficient and effective problem resolution and management, enhanced focus on research and development (R&D) activities, rapid technological advancements, and significant growth in the healthcare industry represent some of the key factors driving the market.
Life sciences business process outsourcing (BPO) involves outsourcing various business processes and functions to a third-party provider in the life sciences industry. It provides specialized services to support the operations and growth of organizations. It is widely used in clinical trials, pharmacovigilance, medical writing, and data management. Life sciences BPO offers various advantages, including access to specialized expertise, cost savings, operational efficiency, scalability, and improved regulatory compliance. It encompasses a broad range of activities and services that support the operations, research, development, manufacturing, and regulatory compliance of companies in the life sciences field, which includes pharmaceuticals, biotechnology, medical devices, clinical research, and healthcare.
The increasing prevalence of chronic diseases across the globe is one of the key factors driving the market growth. Life sciences BPO providers help to collect, analyze, organize, and report complex healthcare data. In line with this, BPO services enable better insights into disease patterns, treatment outcomes, and patient populations, contributing to the development of personalized medicine and evidence-based healthcare solutions, which in turn is favoring the market growth. Apart from this, rapid technological advancements, such as cloud computing, big data analytics, artificial intelligence (AI), and robotic process automation (RPA), enable BPO providers to offer advanced data management, analytics, and automation solutions are providing an impetus to the market growth. Moreover, life sciences BPO offers cost-saving opportunities for companies by reducing operational costs associated with infrastructure setup, staffing, training, and maintenance, which is positively influencing the market growth. Other factors, including the growing need for efficient and effective problem resolution and management, enhanced focus on research and development (R&D) activities, the increasing complexity of the information technology (IT) environment, and significant growth in the pharmacovigilance sector, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global life sciences BPO market, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on service type and application.
Pharmaceutical Outsourcing
Contract Manufacturing Organizations
API
Finished Dose Form
Packaging
Contract Research Organizations
Drug Discovery
Preclinical Studies
Clinical Trial Studies
Regulatory Services
Pharmacovigilance
Medical Devices Outsourcing
Contract Manufacturing Organizations
Electronic Manufacturing Services
Finished Goods
Raw Materials/ Components
Contract Research Organizations
Regulatory Consulting Services
Product Design and Development Services
Product Testing Services
Product Upgrade Services
Product Maintenance Services
Contract Sales and Marketing Outsourcing
The report has provided a detailed breakup and analysis of the life sciences BPO market based on the service type. This includes pharmaceutical outsourcing {contract manufacturing organizations (API, finished dose form, and packaging) and contract research organizations (drug discovery, preclinical studies, clinical trial studies, regulatory services, and pharmacovigilance)}, medical devices outsourcing {contract manufacturing organizations (electronic manufacturing services, finished goods, and raw materials/ components), and contract research organizations (regulatory consulting services, product design and development services, product testing services, product upgrade services, and product maintenance services)}, and contract sales and marketing outsourcing. According to the report, pharmaceutical outsourcing represented the largest segment.
Clinical Trials
Patient-Centric
R&D Activities
Digital Era
A detailed breakup and analysis of the life sciences BPO market based on the application has also been provided in the report. This includes clinical trials, patient-centric, R&D activities, and digital era.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for life sciences BPO. Some of the factors driving the Asia Pacific life sciences BPO market included the growing need for efficient and effective problem resolution and management, enhanced focus on research and development (R&D) activities, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global life sciences BPO market. Detailed profiles of all major companies have been provided. Some of the companies covered include Accenture plc, Cognizant, Genpact Ltd., IQVIA Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.